Compound Q&A
What is the market or research trend for L-alpha-Aspartyl-L-seryl-L-phenylalanyl-L-valyl-beta-alanyl-L-leucyl-L-methioninamide (CAS: 122063-01-8)?
Answer
The market and research trends for L-alpha-Aspartyl-L-seryl-L-phenylalanyl-L-valyl-beta-alanyl-L-leucyl-L-methioninamide (CAS: 122063-01-8) are predominantly focused on its potential applications in biotechnology and pharmaceuticals. This compound is a complex peptide that shows promise in various research areas, including drug discovery and targeted therapy. Recent studies highlight its use in developing novel treatments for diseases such as cancer and neurodegenerative disorders. Additionally, there is growing interest in its potential as a therapeutic agent, which could lead to increased demand and investment in related research.
About
CAS No
122063-01-8
English Name
L-alpha-Aspartyl-L-seryl-L-phenylalanyl-L-valyl-beta-alanyl-L-leucyl-L-methioninamide
Molecular Formula
C35H56N8O10S
Molecular Weight
780.95 g/mol
SMILES
CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CCNC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CC(=O)O)N
InChIKey
CKNPSJOMUQBPLA-WTWMNNMUSA-N
Last Updated: 2025-11-27 19:31
